Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.


AIMS We sought to assess the safety and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) in percutaneous chronic total occlusion (CTO) revascularisation guided by intracoronary imaging. The feasibility of using the BVS in CTO lesions is unknown. METHODS AND RESULTS Thirty-five consecutive true CTO lesions (EuroCTO Club… (More)
DOI: 10.4244/EIJY14M12_07


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.